maltofer fol 100mg/0,35mg Žvýkací tableta
vifor france, paris array - 2222 ŽelezitÁ sŮl polymaltosy; 644 kyselina listovÁ - Žvýkací tableta - 100mg/0,35mg - komplex Železa s isomaltosou a kyselina listovÁ
maltofer fol
vifor france, francúzsko - Železo v kombinácii s kyselinou listovou - 12 - antianaemica
maltofer 10mg/ml sirup
vifor france, paris array - 2222 ŽelezitÁ sŮl polymaltosy - sirup - 10mg/ml - komplex Železa s isomaltosou
maltofer 100mg Žvýkací tableta
vifor france, paris array - 2222 ŽelezitÁ sŮl polymaltosy - Žvýkací tableta - 100mg - komplex Železa s isomaltosou
maltofer 50mg/ml perorální kapky, roztok
vifor france, paris array - 2222 ŽelezitÁ sŮl polymaltosy - perorální kapky, roztok - 50mg/ml - komplex Železa s isomaltosou
maltofer
vifor france, francúzsko - komplexy oxid železitý-polymaltóza - 12 - antianaemica
maltofer
vifor france, francúzsko - komplexy oxid železitý-polymaltóza - 12 - antianaemica
maltofer
vifor france, francúzsko - komplexy oxid železitý-polymaltóza - 12 - antianaemica
maltofer drops
aspen pharmacare australia pty ltd - iron polymaltose, quantity: 185 mg/ml (equivalent: iron, qty 50 mg/ml) - oral liquid - excipient ingredients: sodium propyl hydroxybenzoate; sodium methyl hydroxybenzoate; purified water; sucrose; sodium hydroxide; flavour - treatment of iron deficiency in adults and adolescents where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate.,prevention of iron deficiency in adults and adolescents at high risk where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate.
maltofer syrup
aspen pharmacare australia pty ltd - iron polymaltose, quantity: 37 mg/ml (equivalent: iron, qty 10 mg/ml) - oral liquid - excipient ingredients: propyl hydroxybenzoate; purified water; sorbitol solution (70 per cent) (non-crystallising); ethanol; sucrose; sodium hydroxide; methyl hydroxybenzoate; flavour - treatment of iron deficiency in adults and adolescents where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate. prevention of iron deficiency in adults and adolescents at high risk where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate.